Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Align Technology (ALGN) or West Pharmaceutical Services (WST). But which of these two stocks is more attractive to value investors?

West Pharmaceutical expands Dublin facility to boost injectable therapy capacity and strengthen its end-to-end manufacturing platform.

I am shifting capital allocation toward scarcity-driven assets like energy, metals, infrastructure, and defense, as the abundance trade in software faces structural disruption from AI. My TOLL framework prioritizes companies with hard assets, durable competitive moats, and long-duration cash flows that are less vulnerable to AI-driven commoditization. Key investment themes include nuclear utilities (VST, CEG), copper producers (FCX), gold/silver streamers (FNV, WPM), grid/infrastructure suppliers (ETN, FIX), and defense/aerospace leaders (RTX, TDG).

EXTON, Pa., March 31, 2026 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today the opening of its new building at its current site in Damastown, Dublin. The 165,000 square foot expansion significantly enhances West's contract services and is designed to meet growing global demands of its customers' high-volume treatments, including diabetes and obesity.

Wealth Enhancement Advisory Services LLC trimmed its stake in shares of West Pharmaceutical Services, Inc. (NYSE: WST) by 26.4% in the undefined quarter, according to its most recent disclosure with the SEC. The institutional investor owned 21,480 shares of the medical instruments supplier's stock after selling 7,693 shares during the period. Wealth Enhancement

Investors interested in stocks from the Medical - Dental Supplies sector have probably already heard of Align Technology (ALGN) and West Pharmaceutical Services (WST). But which of these two companies is the best option for those looking for undervalued stocks?

West Pharmaceutical Services, Inc. (WST) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript

Cinctive Capital Management LP bought a new stake in shares of West Pharmaceutical Services, Inc. (NYSE: WST) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund bought 14,319 shares of the medical instruments supplier's stock, valued at approximately $3,756,000. Other institutional

Brown Brothers Harriman and Co. lifted its holdings in West Pharmaceutical Services, Inc. (NYSE: WST) by 22.2% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 247,356 shares of the medical instruments supplier's stock after purchasing an

Middle East tensions rattle markets as oil tops $100. Atmos Energy, Colgate-Palmolive and West Pharmaceutical Services stand out as dividend aristocrats for stability.